Description Code
Ledipasvir 90 mg + Sofosbuvir 400 mg
HIV, Pharmaceutical Products
Ledipasvir 90 mg + Sofosbuvir 400 mg
Fixed-dose combination anti-HCV tablet containing Ledipasvir 90 mg and Sofosbuvir 400 mg for chronic hepatitis C virus infection.
Form: Film-coated tablet
Manufacturer: Cipla Ltd.
Country of Origin: India
| Composition | Ledipasvir 90 mg + Sofosbuvir 400 mg |
|---|---|
| Pack Size | Strip of 28 tablets |
| Form | Film-coated tablet |
| Administration Route | fixed time daily), Oral (with or without food |
| Dosage Regimen | One tablet once daily for 12 or 24 weeks (as prescribed) |
| Usage Indications | Chronic HCV infection (Genotype 1, etc.) |
| Country of Origin | India |
| Manufacturer | Cipla Ltd. |
| Prescription Status | Rx required |
| Storage Conditions | Store below 30 °C in a dry place |
| Shelf Life | 24 months (typical) |
| Common Side Effects | diarrhea, headache, insomnia, irritability, nausea, rash, Tiredness |
| Precautions | Not recommended with amiodarone; avoid alcohol; monitor liver/kidney function; complete full course |
Related products
Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg + Efavirenz 600 mg
HIVFixed-dose combination tablet of Tenofovir Disoproxil Fumarate 300 mg, Emtricitabine 200 mg, and Efavirenz 600 mg, used for HIV-1 treatment.
Tenofovir Alafenamide 25 mg
HIVTenofovir Alafenamide 25 mg tablet used in the treatment of chronic hepatitis B (HBV) infection.
Sofosbuvir 400 mg per tablet
HIVSofosbuvir 400 mg tablet, a potent antiviral agent used in combination therapy for chronic hepatitis C (HCV).
Reviews
There are no reviews yet.